Ironwood Pharms Inc Company Profile
What is the competitive landscape for IRONWOOD PHARMS INC
IRONWOOD PHARMS INC has two approved drugs.
There are eight US patents protecting IRONWOOD PHARMS INC drugs.
Drugs and US Patents for Ironwood Pharms Inc
Expired US Patents for Ironwood Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-001 | Aug 18, 2017 | 8,003,681 | ⤷ Start Trial |
| Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-002 | Aug 18, 2017 | 8,003,681 | ⤷ Start Trial |
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | 8,003,681 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Ironwood Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 2658846 | ⤷ Start Trial |
| Hungary | E031766 | ⤷ Start Trial |
| Eurasian Patent Organization | 201270666 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2010028190 | ⤷ Start Trial |
| Ecuador | SP10010310 | ⤷ Start Trial |
| Croatia | P20140950 | ⤷ Start Trial |
| Mexico | 2011002449 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ironwood Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2217577 | CA 2019 00003 | Denmark | ⤷ Start Trial | PRODUCT NAME: DUZALLO - ALLOPURINOL/LESINURAD OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SALTS THEREOF; REG. NO/DATE: EU/1/18/1300 20180827 |
| 2217577 | 201940004 | Slovenia | ⤷ Start Trial | PRODUCT NAME: ALLOPURINOL/LESINURAD OR ITS PHARMACEUTICALLY ACCEPTABLE SALT OR SALTS; NATIONAL AUTHORISATION NUMBER: EU/1/18/1300; DATE OF NATIONAL AUTHORISATION: 20180823; AUTHORITY FOR NATIONAL AUTHORISATION: EU |
| 2135608 | 34/2016 | Austria | ⤷ Start Trial | PRODUCT NAME: LESINURAD ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1080 (MITTEILUNG) 20160222 |
| 2217577 | C20190007 00276 | Estonia | ⤷ Start Trial | PRODUCT NAME: ALLOPURINOOL/LESINURAAD;REG NO/DATE: EU/1/18/1300 27.08.2018 |
| 2217577 | 2019C/502 | Belgium | ⤷ Start Trial | PRODUCT NAME: DUZALLO - ALLOPURINOL / LESINURAD OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE OU UN DE SES SELS; AUTHORISATION NUMBER AND DATE: EU/1/18/1300 20180827 |
| 2135608 | 93169 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: LESINURAD , OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION DATE: 20160222 |
| 2135608 | 2016C/039 | Belgium | ⤷ Start Trial | PRODUCT NAME: LESINURAD, OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/15/1080 20160222 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.

